-
1
-
-
78650806538
-
Predictors of multidrug- And extensively drug-resistant tuberculosis in a high HIV prevalence community
-
Andrews JR, et al. 2010. Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community. PLoS One 5:e15735.
-
(2010)
PLoS One
, vol.5
-
-
Andrews, J.R.1
-
2
-
-
0036226416
-
Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir
-
DOI 10.1016/S0166-3542(01)00220-0, PII S0166354201002200
-
Bray M, et al. 2002. Treatment of aerosolized cowpox virus infection in mice with aerosolized cidofovir. Antiviral Res. 54:129-142. (Pubitemid 34327679)
-
(2002)
Antiviral Research
, vol.54
, Issue.3
, pp. 129-142
-
-
Bray, M.1
Martinez, M.2
Kefauver, D.3
West, M.4
Roy, C.5
-
3
-
-
0030961425
-
Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol
-
DOI 10.1016/S0140-6736(96)12273-X
-
Condos R, Rom WN, Schluger NW. 1997. Treatment of multidrug-resistant pulmonary tuberculosis with interferon-gamma via aerosol. Lancet 349:1513-1515. (Pubitemid 27216363)
-
(1997)
Lancet
, vol.349
, Issue.9064
, pp. 1513-1515
-
-
Condos, R.1
Rom, W.N.2
Schluger, N.W.3
-
4
-
-
77951883143
-
Genetic requirements for the survival of tubercle bacilli in primates
-
Dutta NK, et al. 2010. Genetic requirements for the survival of tubercle bacilli in primates. J. Infect. Dis. 201:1743-1752.
-
(2010)
J. Infect. Dis.
, vol.201
, pp. 1743-1752
-
-
Dutta, N.K.1
-
5
-
-
70249142207
-
Trends in tuberculosis incidence and their determinants in 134 countries
-
Dye C, et al. 2009. Trends in tuberculosis incidence and their determinants in 134 countries. Bull. World Health Organ. 87:683-691.
-
(2009)
Bull. World Health Organ.
, vol.87
, pp. 683-691
-
-
Dye, C.1
-
6
-
-
0028919421
-
Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes
-
Gangadharam PR, et al. 1995. Therapy of Mycobacterium avium complex infections in beige mice with streptomycin encapsulated in sterically stabilized liposomes. Antimicrob. Agents Chemother. 39:725-730.
-
(1995)
Antimicrob. Agents Chemother.
, vol.39
, pp. 725-730
-
-
Gangadharam, P.R.1
-
7
-
-
77951838895
-
Prevention of tuberculosis in people living with HIV
-
Granich R, et al. 2010. Prevention of tuberculosis in people living with HIV. Clin. Infect. Dis. 50:S215-S222.
-
(2010)
Clin. Infect. Dis.
, vol.50
-
-
Granich, R.1
-
8
-
-
0037062452
-
Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH
-
DOI 10.1073/pnas.102055799
-
Kaushal D, et al. 2002. Reduced immunopathology and mortality despite tissue persistence in a Mycobacterium tuberculosis mutant lacking alternative sigma factor, SigH. Proc. Natl. Acad. Sci. U. S. A. 99:8330-8335. (Pubitemid 34651052)
-
(2002)
Proceedings of the National Academy of Sciences of the United States of America
, vol.99
, Issue.12
, pp. 8330-8335
-
-
Kaushal, D.1
Schroeder, B.G.2
Tyagi, S.3
Yoshimatsu, T.4
Scott, C.5
Ko, C.6
Carpenter, L.7
Mehrotra, J.8
Manabe, Y.C.9
Fleischmann, R.D.10
Bishai, W.R.11
-
9
-
-
0025109172
-
Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco Community Prophylaxis Trial
-
Leoung GS, et al. 2001. Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco Community Prophylaxis Trial. N. Engl. J. Med. 323:769-775.
-
(2001)
N. Engl. J. Med.
, vol.323
, pp. 769-775
-
-
Leoung, G.S.1
-
10
-
-
77958003946
-
Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas
-
Mehra S, et al. 2010. Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas. PLoS One 5:e12266.
-
(2010)
PLoS One
, vol.5
-
-
Mehra, S.1
-
11
-
-
79960650456
-
Reactivation of latent tuberculosis in rhesus macaques by coinfection with simian immunodeficiency virus
-
Mehra S, et al. 2011. Reactivation of latent tuberculosis in rhesus macaques by coinfection with simian immunodeficiency virus. J. Med. Primatol. 40:233-243.
-
(2011)
J. Med. Primatol.
, vol.40
, pp. 233-243
-
-
Mehra, S.1
-
12
-
-
0033531143
-
Intermittent administration of inhaled tobramycin in patients with cystic fibrosis
-
DOI 10.1056/NEJM199901073400104
-
Ramsey BW, et al. 1999. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis: cystic fibrosis inhaled tobramycin study group. N. Engl. J. Med. 340:23-30. (Pubitemid 29024680)
-
(1999)
New England Journal of Medicine
, vol.340
, Issue.1
, pp. 23-30
-
-
Ramsey, B.W.1
Pepe, M.S.2
Quan, J.M.3
Otto, K.L.4
Montgomery, A.B.5
Williams-Warren, J.6
Vasiljev-K, M.7
Borowitz, D.8
Bowman, C.M.9
Marshall, B.C.10
Marshall, S.11
Smith, A.L.12
-
13
-
-
0034900387
-
Treatment of ulcerative endobronchial tuberculosis and bronchial stenosis with aerosolized streptomycin and steroids
-
Rikimaru T, et al. 2001. Treatment of ulcerative endobronchial tuberculosis and bronchial stenosis with aerosolized streptomycin and steroids. Int. J. Tuberc. Lung Dis. 5:769-774. (Pubitemid 32720562)
-
(2001)
International Journal of Tuberculosis and Lung Disease
, vol.5
, Issue.8
, pp. 769-774
-
-
Rikimaru, T.1
Koga, T.2
Sueyasu, Y.3
Ide, S.4
Kinosita, M.5
Sugihara, E.6
Oizumi, K.7
-
14
-
-
0019881337
-
Gentamicin aerosol therapy in 18 dogs: Failure to induce detectable serum concentrations of the drug
-
Riviere JE, et al. 1981. Gentamicin aerosol therapy in 18 dogs: failure to induce detectable serum concentrations of the drug. J. Am. Vet. Med. Assoc. 179:166-168.
-
(1981)
J. Am. Vet. Med. Assoc.
, vol.179
, pp. 166-168
-
-
Riviere, J.E.1
-
15
-
-
0035134275
-
Adjunctive salvage therapy with inhaled aminoglycosides for patients with persistent smear-positive pulmonary tuberculosis
-
DOI 10.1086/317524
-
Sacks LV, et al. 2001. Adjunctive salvage therapy with inhaled aminoglycosides for patients with persistent smear-positive pulmonary tuberculosis. Clin. Infect. Dis. 32:44-49. (Pubitemid 32150949)
-
(2001)
Clinical Infectious Diseases
, vol.32
, Issue.1
, pp. 44-49
-
-
Sacks, L.V.1
Pendle, S.2
Orlovic, D.3
Andre, M.4
Popara, M.5
Moore, G.6
Thonell, L.7
Hurwitz, S.8
-
16
-
-
0030769223
-
Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis
-
Telzak EE, et al. 1997. Factors influencing time to sputum conversion among patients with smear-positive pulmonary tuberculosis. Clin. Infect. Dis. 25:666-670. (Pubitemid 127774281)
-
(1997)
Clinical Infectious Diseases
, vol.25
, Issue.3
, pp. 666-670
-
-
Telzak, E.E.1
Fazal, B.A.2
Pollard, C.L.3
Turett, G.S.4
Justman, J.E.5
Bluni, S.6
|